- DXC Technology recently announced expanded Assure Platform capabilities and Assure Smart Apps, aimed at helping insurers modernize critical operations, automate workflows, and adopt AI within governed, resilient environments across both global and London insurance markets.
- The firm also completed delivery of the Minerals and Energy Regulation System for South Australia, showing DXC Technology applying the same cloud and AI tooling used in insurance to complex public sector regulation workloads.
- We will now look at how DXC Technology's push to scale Assure Smart Apps and AI-led insurance workflows could influence its investment narrative.
DXC Technology Investment Narrative Recap
To own DXC Technology you need to believe the shift from shrinking, labor heavy IT contracts toward higher margin software, SaaS and AI tooling can eventually outweigh current revenue pressure. The fresh Assure Platform and Smart Apps news speaks directly to that story. It reinforces that insurance software is where DXC is trying to lean into recurring, product based income.
The near term swing factor is still whether bookings in these AI led offerings can slow the guided 3% to 5% organic revenue decline and support margins after recent compression, especially in GIS. The key risk remains execution. If uptake of new platforms stalls or large projects slip, already thin 1% net margins and high debt become more uncomfortable.
The expansion of Assure Smart Apps and the broader Assure Platform looks most relevant right now. Management has flagged that recurring software, SaaS and AI revenue in insurance has been growing at 24%. The new London Market focused workflows and governed AI tooling fit squarely into that higher quality revenue mix and are now being rolled out at scale.
Assure metrics already reported, such as 18 Smart App customers supporting more than 450 insurers and over 750,000 automated transactions, give you tangible adoption to track against bookings momentum. For a shareholder, the question is whether similar platform deployments, including the Minerals and Energy Regulation System in South Australia, can offset weakness in GIS and help move DXC closer to its long term 8% to 10% adjusted EBIT margin ambition.
DXC Technology's narrative projects US$11.9b revenue and US$169.4 million earnings by 2029. This assumes a 1.7% yearly revenue decline and an earnings increase of about US$45 million from the US$124.0 million reported today.
Uncover why DXC Technology's fair value indicates a 7% potential downside to its current price. This reflects a valuation premium that leaves little room for error.
Exploring Other Perspectives
One alternate view is that DXC Technology still struggles to turn AI projects into enough hard cash flow. The most bearish analysts were pencilling in revenue of about US$11.8b and earnings of roughly US$179.7 million by 2029 before this Assure news, yet still saw a much lower P/E as appropriate. You may read that as a clear signal that opinion is split, and use it as a prompt to explore several different forecasts before deciding how meaningful these new insurance and public sector wins could become.
Explore 3 other DXC Technology fair value estimates, including one that suggests as much as 25% downside from the current price.
The Verdict Is Yours
Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.
- A great starting point for your DXC Technology research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
- See our latest analysis for DXC Technology. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate DXC Technology's overall financial health at a glance.
Looking For More Ideas Beyond DXC Technology?
If DXC Technology has sparked some fresh questions about where to put capital to work next, it can help to line it up against a broader watchlist. The Simply Wall St Screener lets you scan for companies with specific traits, so you can compare DXC against very different business models and risk profiles instead of viewing it in isolation.
- If you care most about valuation support and a margin of safety, start by reviewing 29 high quality undervalued stocks to see which businesses the Screener currently flags as trading below their assessed worth.
- For investors who want staying power front and center, lean on a list of solid balance sheet and fundamentals (25 results) that can handle shocks without constant refinancing concerns.
- If you enjoy finding less crowded ideas before they hit the headlines, scan through 20 high quality undiscovered gems and see which quieter tickers already have strong fundamentals in place.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com